Matches in Nanopublications for { ?s ?p "DDI between Bromocriptine and Zuclopenthixol acetate - Antagonism may occur between zuclopenthixol, a dopamine D2 receptor antagonist, and bromocriptine, a dopamine agonist. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of both agents if concurrent therapy is initiated, discontinued or dose(s) changed. [drugbank_resource:DB01200_DB08919]"@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- drugbank_resource:DB01200_DB08919 label "DDI between Bromocriptine and Zuclopenthixol acetate - Antagonism may occur between zuclopenthixol, a dopamine D2 receptor antagonist, and bromocriptine, a dopamine agonist. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of both agents if concurrent therapy is initiated, discontinued or dose(s) changed. [drugbank_resource:DB01200_DB08919]" assertion.